UBI — Universal Biosensors Share News
0.000.00%
HealthcareSpeculativeMicro Cap
Brief: Universal Biosensors Says Xprecia Prime 4U Approved For Patient Self-Testing In Europe
Brief: Universal Biosensors Got Approval From Indian Central Drugs Standard Control Organisation For Sale Of Xprecia Prime
Brief: Universal Biosensors Says Xprecia Prime Tender Win In Italy
Brief: Universal Biosensors Says HY Loss Attributable A$2.4 Million
Brief: Universal Biosensors Posts Qtrly Net Loss Of A$3.8 Million
Brief: Universal Biosensors Signs Multiple Distribution Deals In U.S. And Canada
Brief: Universal Biosensors Posts FY Revenue From Ordinary Activities A$4.5 Million
Universal Biosensors rises on first device delivery after delays
Brief: Universal Biosensors Sees Better 2023 Sales Performance From Coagulation Unit
Brief: Universal Biosensors Inc Says Graham Mclean Has Been Appointed Chairman
Brief: Universal Biosensors Says HY Revenue From Ordinary Activities Down 9% To A$3.1 Mln
Brief: Universal Biosensors Announces New Distribution Deals In Europe And Glucose Test Launch
Australia's Universal Biosensors gains on distribution deals for Europe
Australia's Universal Biosensors jumps on placement proceeds
Brief: Universal Biosensors Considers Establishment Of Foreign Ownership Restriction Designation For CDIs
Australia's Universal Biosensors hits 4-1/2-month low on discounted placement
Brief: Universal Biosensors Raised A$6M Via Institutional Placement Of New Chess Depositary Interests At Issue Price Of A$0.77 Per New Cdi
Brief: Universal Biosensors Says Fully Underwritten Entitlement Offer To Raise A$20M Plus Institutional Placement To Raise A Minimum Of A$5M
Brief: Universal Biosensors Seeks Trading Halt